PL EN

MHRA: Guidance on signposting from patient information leaflets

19.05.2009
This guidance has been developed by the MHRA with advice from the Commission on Human Medicines Expert Advisory Group on Patient Information and in consultation with industry representatives. It builds on previous work by the Committee on Safety of Medicines Working Group on Patient Information.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny